This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Apr;164(4):699.

doi: 10.1053/j.gastro.2022.10.004. Epub 2022 Oct 8.

Vonoprazan May Induce Clostridium difficile Infection and Nephrotoxicity

Mingyu Yang¹, Chuanli Ren¹, Zhanjun Yang²

Affiliations

Affiliations

¹ Department of Laboratory Medicine, Clinical Medical College of Yangzhou University, Yangzhou, China.
² Department of Clinical Chemistry, Yangzhou University, Yangzhou, China.

PMID: 36220458
DOI: 10.1053/j.gastro.2022.10.004

Comment

Vonoprazan May Induce Clostridium difficile Infection and Nephrotoxicity

Mingyu Yang et al. Gastroenterology. 2023 Apr.

. 2023 Apr;164(4):699.

doi: 10.1053/j.gastro.2022.10.004. Epub 2022 Oct 8.

Authors

Mingyu Yang¹, Chuanli Ren¹, Zhanjun Yang²

Affiliations

¹ Department of Laboratory Medicine, Clinical Medical College of Yangzhou University, Yangzhou, China.
² Department of Clinical Chemistry, Yangzhou University, Yangzhou, China.

PMID: 36220458
DOI: 10.1053/j.gastro.2022.10.004

No abstract available

PubMed Disclaimer

Comment on

Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.
Chey WD, Mégraud F, Laine L, López LJ, Hunt BJ, Howden CW. Chey WD, et al. Gastroenterology. 2022 Sep;163(3):608-619. doi: 10.1053/j.gastro.2022.05.055. Epub 2022 Jun 6. Gastroenterology. 2022. PMID: 35679950 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science